blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2351743

EP2351743 - BICYCLIC COMPOUND [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  28.08.2015
Database last updated on 20.07.2024
Most recent event   Tooltip28.08.2015Application deemed to be withdrawnpublished on 30.09.2015  [2015/40]
Applicant(s)For all designated states
Takeda Pharmaceutical Company Limited
1-1 Doshomachi 4-chome Chuo-ku
Osaka-shi, Osaka 541-0045 / JP
[2011/31]
Inventor(s)01 / KAMATA, Makoto
c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED
17-85, Jusohonmachi 2-chome
Yodogawa-ku
Osaka-shi Osaka 532-8686 / JP
02 / YAMASHITA, Tohru
c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED
17-85, Jusohonmachi 2-chome
Yodogawa-ku
Osaka-shi Osaka 532-8686 / JP
03 / KINA, Asato
c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED
17-85, Jusohonmachi 2-chome
Yodogawa-ku
Osaka-shi Osaka 532-8686 / JP
04 / TAWADA, Michiko
c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED
26-1, Muraoka-Higashi 2-chome
Fujisawa Kanagawa 251-0012 / JP
 [2011/51]
Former [2011/50]01 / KAMATA, Makoto
c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED
17-85, Jusohonmachi 2-chome
Yodogawa-ku
Osaka-shi Osaka 532-8686 / JP
02 / YAMASHITA, Tohru
c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED
17-85, Jusohonmachi 2-chome
Yodogawa-ku
Osaka-shi Osaka 532-8686 / JP
03 / KINA, Asato
c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED
17-85, Jusohonmachi 2-chome
Yodogawa-ku
Osaka-shi Osaka 532-8686 / JP
04 / TAWADA, Michiko
c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED
26-1, Muraoko-Higashi 2-chome
Fujisawa Kanagawa 251-0012 / JP
Former [2011/31]01 / KAMATA, Makoto
c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED 17-85, Jusohonmachi 2-chome Yodogawa-ku
Osaka-shi Osaka 532-8686 / JP
02 / YAMASHITA, Tohru
c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED 17-85, Jusohonmachi 2-chome Yodogawa-ku
Osaka-shi Osaka 532-8686 / JP
03 / KINA, Asato
c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED 17-85, Jusohonmachi 2-chome Yodogawa-ku
Osaka-shi Osaka 532-8686 / JP
04 / AMANO, Michiko
c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED 17-85, Jusohonmachi 2-chome Yodogawa-ku
Osaka-shi Osaka 532-8686 / JP
Representative(s)Jones, Nicholas Andrew, et al
Withers & Rogers LLP
2 London Bridge
London SE1 9RA / GB
[N/P]
Former [2011/31]Jones, Nicholas Andrew, et al
Withers & Rogers LLP Goldings House 2 Hays Lane London
SE1 2HW / GB
Application number, filing date09823555.926.10.2009
[2011/31]
WO2009JP68356
Priority number, dateJP2008027617127.10.2008         Original published format: JP 2008276171
JP2009003746820.02.2009         Original published format: JP 2009037468
JP2009014276915.06.2009         Original published format: JP 2009142769
[2011/31]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2010050445
Date:06.05.2010
Language:JA
[2010/18]
Type: A1 Application with search report 
No.:EP2351743
Date:03.08.2011
Language:EN
[2011/31]
Search report(s)International search report - published on:JP06.05.2010
(Supplementary) European search report - dispatched on:EP12.04.2012
ClassificationIPC:C07D235/14, A61K31/343, A61K31/423, A61K31/428, A61K31/4355, A61K31/437, A61K31/443, A61P3/04, A61P3/06, A61P3/10, A61P9/04, A61P9/12, A61P21/00, A61P35/00, C07D405/06, C07D407/06, C07D417/12, C07D491/04, A61K31/4196
[2012/24]
CPC:
C07D235/14 (EP,US); A61P1/04 (EP); A61P1/16 (EP);
A61P1/18 (EP); A61P11/00 (EP); A61P11/04 (EP);
A61P13/10 (EP); A61P13/12 (EP); A61P15/00 (EP);
A61P19/02 (EP); A61P19/10 (EP); A61P21/00 (EP);
A61P25/16 (EP); A61P25/22 (EP); A61P25/28 (EP);
A61P29/00 (EP); A61P3/00 (EP); A61P3/04 (EP);
A61P3/06 (EP); A61P3/10 (EP); A61P31/00 (EP);
A61P35/00 (EP); A61P35/02 (EP); A61P43/00 (EP);
A61P5/00 (EP); A61P7/00 (EP); A61P9/04 (EP);
A61P9/10 (EP); A61P9/12 (EP); C07D261/20 (EP,US);
C07D263/56 (EP,US); C07D277/64 (EP,US); C07D307/81 (EP,US);
C07D333/58 (EP,US); C07D405/06 (EP,US); C07D405/12 (EP,US);
C07D407/06 (EP,US); C07D407/12 (EP,US); C07D413/12 (EP,US);
C07D417/12 (EP,US); C07D471/04 (EP,US); C07D491/04 (EP,US);
C07D491/048 (EP,US) (-)
Former IPC [2011/31]C07D235/14, A61K31/343, A61K31/381, A61K31/4155, A61K31/4184, A61K31/42, A61K31/422, A61K31/423, A61K31/427, A61K31/428, A61K31/433, A61K31/4355, A61K31/437, A61K31/443, A61P3/04, A61P3/06, A61P3/10, A61P9/04, A61P9/12, A61P21/00, A61P35/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2011/31]
TitleGerman:BICYCLISCHE VERBINDUNG[2011/31]
English:BICYCLIC COMPOUND[2011/31]
French:COMPOSÉ BICYCLIQUE[2011/31]
Entry into regional phase27.04.2011Translation filed 
27.04.2011National basic fee paid 
27.04.2011Search fee paid 
27.04.2011Designation fee(s) paid 
27.04.2011Examination fee paid 
Examination procedure27.04.2011Examination requested  [2011/31]
31.10.2012Amendment by applicant (claims and/or description)
10.12.2012Despatch of a communication from the examining division (Time limit: M04)
16.04.2013Reply to a communication from the examining division
01.05.2015Application deemed to be withdrawn, date of legal effect  [2015/40]
28.05.2015Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2015/40]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  10.12.2012
Fees paidRenewal fee
20.10.2011Renewal fee patent year 03
18.10.2012Renewal fee patent year 04
29.10.2013Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.10.201406   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XP]WO2009110985  (RENOVIS INC [US], et al) [XP] 1-9,14,15,17,18 * claims, esp. 67, 77 *;
 [XP]WO2009110520  (TAKEDA PHARMACEUTICAL [JP], et al) [XP] 1-4,6-9,14,15,17,18 * compounds 219-221, 288-293, 299-306, 312, 328, 343 *;
 EP2251326  [ ] (TAKEDA PHARMACEUTICAL [JP]);
 [XP]WO2009079011  (FENG YANGBO [US], et al) [XP] 1-9,14,15,17,18 * claims, esp. 53, 56, 71, 73 *;
 [XP]WO2009026701  (METHYLGENE INC [CA], et al) [XP] 1-9,14,15,17,18 * claims, esp. 106, 108-110 *;
 [X]WO2007064993  (OSI PHARM INC [US], et al) [X] 1-9,14,15,17,18 * claims esp. 14, 17, 18, 20, 22, 24-26 *;
 [X]WO2007022241  (SCHERING CORP [US], et al) [X] 1-9,14,15,17,18 * claims, esp. 57, 60-62 *;
 [X]WO2007018314  (TAKEDA PHARMACEUTICAL [JP], et al) [X] 1-9,14,15,17,18 * pages 47-50; claim - *;
 [X]WO2007002764  (SCHERING CORP [US], et al) [X] 1-9,14,15,17,18 * pages 48, 49; claims esp. 65, 66, 70, 74 *;
 [X]WO2006094209  (SIRTRIS PHARMACEUTICALS INC [US], et al) [X] 1-9,14,15,17,18 * abstract *;
 [X]WO2006044823  (AMGEN INC [US], et al) [X] 1-9,14,15,17,18 * pages 235, 238, 240, 241; claims esp. 24, 25, 28, 32, 40,42,47; pages 235, 238 *;
 [X]WO2006036932  (ELIXIR PHARMACEUTICALS INC [US], et al) [X] 1-9,14,15,17,18 * claims, esp. 18-20 *;
 [X]WO2006124874  (KALYPSYS INC [US], et al) [X] 1-9,14,15,17,18 * abstract, claims, esp. 26 *;
 [X]WO2005121130  (SCHERING CORP) [X] 1-9,14,15,17,18 * claims, esp. 72-74 *;
 [X]WO2005116001  (7TM PHARMA AS [DK], et al) [X] 1-9,14,15,17,18 * page 5; claim - *;
 [X]WO2005066147  (SCHERING CORP [US], et al) [X] 1-9,14,15,17,18 * claims, esp. 53, 56, 60, 73, 90, 91 *;
 [X]WO2005066137  (NEUROGEN CORP [US], et al) [X] 1-9,14,15,17,18 * claims, esp. 28, 30, 32 *;
 [X]WO2005068460  (SCHERING CORP [US], et al) [X] 1-9,14,15,17,18 * claims, esp. 79, 109, 110 *;
 [X]WO2005103029  (BOEHRINGER INGELHEIM INT [DE], et al) [X] 1-9,14,15,17,18 * pages 48, 49; claim - *;
 [X]WO2004072047  (FUJISAWA PHARMACEUTICAL CO [JP], et al) [X] 1-9,14,15,17,18 * claims, eps. 10-13 *;
 [X]WO2004071448  (TRANSTECH PHARMA INC [US], et al) [X] 1-9,14,15,17,18 * abstract, claims, esp. 31, 32, 37, 38 *;
 [X]WO2004033440  (PHARMACOPEIA INC [US], et al) [X] 1-9,14,15,17,18 * claims, esp. 80 *;
 [X]WO2004021984  (SQUIBB BRISTOL MYERS CO [US], et al) [X] 1-9,14,15,17,18 * pages 1, 38-40; claim - *;
 [X]WO03075921  (TRANSTECH PHARMA INC [US], et al) [X] 1-9,14,15,17,18 * abstract, claims, esp. 34 *;
 [X]WO03057676  (SCHERING CORP [US], et al) [X] 1-9,14,15,17,18 * abstract *;
 [X]WO03045925  (STERIX LTD [GB], et al) [X] 1-9,14,15,17,18 * page 9; claim - *;
 [X]WO02069965  (TRANSTECH PHARMA INC [US], et al) [X] 1-9,14,15,17,18 * pages 1, 3; example - *;
 [X]WO0054729  (SQUIBB BRISTOL MYERS CO [US]) [X] 1-9,14,15,17,18 * page 1; claims, esp. 20, 22, 25 *;
 [X]WO0001704  (BOEHRINGER INGELHEIM PHARMA [DE]) [X] 1-9,14,15,17,18 * pages 41, 42; claim - *;
 [X]WO9965942  (SOD CONSEILS RECH APPLIC [FR], et al) [X] 1-9,14,15,17,18 * pages 25, 26; claim - *;
 [X]WO9509159  (OTSUKA PHARMA CO LTD [JP], et al) [X] 1-9,14,15,17,18 * abstract, page 240, claims *;
 [X]EP1873144  (TAKEDA PHARMACEUTICAL [JP]) [X] 1-9,14,15,17,18 * pages 34, 35; claim - *;
 [X]EP1726580  (TAKEDA PHARMACEUTICAL [JP]) [X] 1-9,14,15,17,18 * abstract, pages 30, 31, claims *;
 [X]EP1559422  (TAKEDA PHARMACEUTICAL [JP]) [X] 1-9,14,15,17,18 * pages 2, 66; claim - *;
 [X]EP1431267  (ONO PHARMACEUTICAL CO [JP]) [X] 1-9,14,15,17,18 * page 2; claim - *;
 [X]EP1285651  (TAKEDA CHEMICAL INDUSTRIES LTD [JP]) [X] 1-9,14,15,17,18 * pages 2, 31; claim - *;
 [X]EP1283199  (TAKEDA CHEMICAL INDUSTRIES LTD [JP]) [X] 1-9,14,15,17,18 * pages 2, 42; claim - *;
 [X]EP0608568  (AMERICAN CYANAMID CO [US]) [X] 1,5,6,8,9 * page 7; compound VII *;
 [X]EP0535926  (MERCK FROSST CANADA INC [CA]) [X] 1-9,14,15,17,18 * abstract, page 5, claims *;
 [Y]WO2007095602  (ABBOTT LAB [US], et al) [Y] 1-18 * abstract *;
 [Y]EP0773019  (ZERIA PHARM CO LTD [JP]) [Y] 1-18 * abstract *
International search[A]JP2006502162  (BRISTOL-MYERS SQUIBB CO.);
 [A]JP2005194191  (AJINOMOTO KK);
 [A]JPS63264456  (ABBOTT LAB);
 [A]JPH07224063  (MERCK FROSST CANADA INC)
by applicantWO2004021984
 WO0054729
 JPH09235278
 WO9509159
 WO03045925
 JP2006131559
 WO2007013691
 WO2007119833
 WO2008090944
 WO2008102749
 WO2007013694
 WO2007018314
 WO2008093639
 WO2008099794
 WO2004041266
 WO2004106276
 WO2005063729
 WO2005063725
 WO2005087710
 WO2005095338
 WO2007013689
 WO2008001931
 WO2006112549
 WO2007028135
 WO2008047821
 WO2008050821
 WO2008136428
 WO2008156757
 WO0114372
 WO2004039365
 WO9710224
 WO0182925
 WO0187834
 WO0206234
 WO2004048363
 WO2005030740
 WO2005058823
 WO2005113504
 US4808595
 US6355660
 US2004087600
 EP1179532
    - TETRAHEDRON LETTERS, (2007), vol. 48, no. 15, pages 2661 - 2665
    - "IYAKUHIN no KAIHATSU", Design of Molecules, HIROKAWA SHOTEN, (1990), vol. 7, pages 163 - 198
    - BIOORGANIC MEDICINAL CHEMISTRY LETTERS, (2007), pages 3630 - 3635
    - JOURNAL OF CHEMICAL SOCIETY, (1937), pages 1530 - 1534
    - TETRAHEDRON LETTERS, (1980), pages 769 - 770
    - JOURNAL OF MEDICINAL CHEMISTRY, (1998), pages 2439 - 2441
    - Jikken Kagaku Kouza, THE CHEMICAL SOCIETY OF JAPAN, vol. 20, pages 304,477 - 479
    - JOURNAL OF MEDICINAL CHEMISTRY, (1998), pages 2146 - 2163
    - SYNLETT, (2005), pages 2130 - 2134
    - JOURNAL OF MEDICINAL CHEMISTRY, (1994), pages 3108 - 3120
    - PHOTOCHEMISTRY, (1971), pages 539 - 544
    - JOURNAL OF ORGANIC CHEMISTRY, (2005), pages 2494 - 2502
    - TETRAHEDRON, (1990), pages 5177 - 5186
    - ORGANIC LETTERS, (2006), pages 5661 - 5664
    - EUROPEAN JOURNAL OF ORGANIC CHEMISTRY, (1999), pages 2609 - 2622
    - TETRAHEDRON LETTERS, (1994), pages 3309 - 3312
    - BIOORGANIC AND MEDICINAL CHEMISTRY, (1999), pages 2945 - 2952
    - JOURNAL OF ORGANIC CHEMISTRY, (1992), pages 1663 - 1671
    - JOURNAL OF ORGANIC CHEMISTRY, (1993), pages 5886 - 5888
    - JOURNAL OF ORGANIC CHEMISTRY, (1990), pages 4892 - 4897
    - TETRAHEDRON, (1990), pages 7663 - 7666
    - SYNLETT, (2006), pages 1255 - 1259
    - TETRAHEDRON, (2005), pages 5253 - 5260
    - JOURNAL OF AMERICAN CHEMICAL SOCIETY, (1938), pages 2084 - 2085
    - JOURNAL OF ORGANIC CHEMISTRY, (2003), pages 5758 - 5761
    - BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS, (2005), pages 2998 - 3001
    - TETRAHEDRON: ASYMMETRY, (1994), pages 1793 - 1804
    - TETRAHEDRON: ASYMMETRY, (2003), pages 689 - 692
    - JOURNAL OF ORGANIC CHEMISTRY, (1997), pages 261 - 274
    - TETRAHEDRON LETTERS, (1989), pages 2581 - 2584
    - EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, (1992), pages 7 - 18
    - JOURNAL OF MEDICINAL CHEMISTRY, (2006), pages 5282 - 5290
    - JOURNAL OF MEDICINAL CHEMISTRY, (1993), pages 2703 - 2705
    - BULLETIN OF CHEMICAL SOCIETY JAPAN, (1983), pages 2762 - 2767
    - JOURNAL OF HETEROCYCLIC CHEMISTRY, (1996), pages 1051 - 1056
    - JOURNAL OF AMERICAN CHEMICAL SOCIETY, (1954), pages 1286 - 1289
    - JOURNAL OF MEDICINAL CHEMISTRY, (2006), pages 8378 - 8383
    - SYNLETT, (2006), pages 1908 - 1912
    - RUSSIAN JOURNAL OF GENERAL CHEMISTRY, (1998), pages 542 - 547
    - JOURNAL OF HETEROCYCLIC CHEMISTRY, (1989), pages 281 - 284
    - JOURNAL OF HETEROCYCLIC CHEMISTRY, (1971), pages 57 - 60
    - JOURNAL OF MEDICINAL CHEMISTRY, (2000), pages 1293 - 1310
    - SYNTHESIS, (1986), pages 749 - 751
    - JOURNAL OF AMERICAN CHEMICAL SOCIETY, (1984), pages 158 - 163
    - BIOORGANIC AND MEDICINAL CHEMICAL LETTERS, (2007), pages 1803 - 1807
    - JOURNAL OF CHEMICAL SOCIETY, (1959), pages 3362 - 3369
    - JOURNAL OF MEDICINAL CHEMISTRY, (1997), pages 2085 - 2101
    - JOURNAL OF FLUORINE CHEMISTRY, (2001), pages 135 - 146
    - JOURNAL OF ORGANIC CHEMISTRY, (1992), pages 565 - 573
    - SYNTHETIC COMMUNICATIONS, (1981), pages 969 - 978
    - JOURNAL OF MEDICINAL CHEMISTRY, (1978), pages 1158 - 1162
    - SYNTHETIC COMMUNICATIONS, (2003), pages 3435 - 3454
    - JOURNAL OF AMERICAN CHEMICAL SOCIETY, (2005), pages 2844 - 2845
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.